Genmab A/S | 2,175.00 |
Date/Time | 05/18 / 10:19 |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | 2,120.00 |
Previous Close | 2,108.00 |
High | 2,175.00 |
Low | 2,119.50 |
Volume [DKK] | 424,853.50 |
Volume [Units] | 199 |
Price fixings | 13 |
ISIN | DK0010272202 |
Security | GMAB/C |
Exchange | Cboe Europe BXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,168.00 | ![]() |
8,144 |
London Inter.. | 2,170.0 | ![]() |
2,299 |
Turquoise | 2,168.00 | ![]() |
1,116 |
München | 283.60 | ![]() |
0 |
Düsseldorf | 291.40 | ![]() |
0 |
Hannover | 282.00 | ![]() |
0 |
Frankfurt | 284.5000 | ![]() |
0 |
Berlin | 285.70 | ![]() |
0 |
Quotrix | 283.0000 | ![]() |
|
Lang & Schwa.. | 291.00 | ![]() |
|
Stuttgart | 289.800 | ![]() |
|
gettex | 290.500 | ![]() |
|
OMX Nordic | 2,126.00 | ![]() |
150,448 |
Nasdaq Other.. | 296.0000 | ![]() |
48,136 |
Cboe Europe .. | 2,175.00 | 199 | |
Cboe Europe .. | 2,154.00 | 67 | |
TradeGate | 285.800 | 7 | |
Vienna Globa.. | 285.40 | 0 | |
Mexico | 7,393.30 | ![]() |
203 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire